首页>
外国专利>
Combination therapy including rituximab and the radiolabelled HH1 monoclonal antibody
Combination therapy including rituximab and the radiolabelled HH1 monoclonal antibody
展开▼
机译:包括利妥昔单抗和放射性标记的HH1单克隆抗体在内的联合疗法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to radioimmunoconjugates that are capable of upregulating expression of one or more antigens. The upregulated antigens can be the antigens that are targeted by the radioimmunoconjugates or different antigens expressed on the same cells. The present invention also relates to methods of treating cancer and diseases and disorders of the immune system by utilizing this enhanced expression of antigens.
展开▼